The global apheresis equipment market comprises equipment utilized for collecting blood components such as plasma, platelets, leukocytes, red blood cells, or stem cells through an apheresis machine. There has been a significant rise in usage of apheresis equipment for collecting specific blood components for transfusion or therapeutic purposes in conditions like leukemia and anemia. The technology enables obtaining the desired blood components efficiently without needing to obtain an entire unit of donor blood. Additionally, apheresis equipment have wide application in therapeutic treatments that involve plasmapheresis or cytapheresis procedures to filter blood components of patients suffering from chronic diseases and immunological disorders.
Apheresis Equipment Market is estimated to be valued at USD 4.76 Bn in 2025 and is expected to reach USD 10.01 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.
Key Takeaways
Asahi Kasei Medical Co., Ltd., Terumo Corporation, Inc., Fenwal, Inc., Haemonetics Corp., Therakos, Inc., B. Braun Melsungen AG, HemaCare Corporation, Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Miltenyi Biotec, NxStage Medical, and Kaneka Medix Corporation
The Apheresis Equipment Market Growth provides immense opportunities for players in terms of continued technological advancements, increasing awareness about therapeutic apheresis procedures, and growing healthcare expenditure in developing nations. Additionally, growing prevalence of autoimmune diseases and rise in transplant procedures drive the growth of the market.
Various companies are also expanding their geographic presence across regions with high market potential and demand for plasma-derived therapeutics in North America, Europe, Asia Pacific, as well as emerging markets. For instance, Terumo Corporation's recent acquisition of global blood transfusion company, Haemonetics Corporation expands its global footprint and product portfolio.
Market drivers
Rising prevalence of chronic diseases such as blood cancer, autoimmune disorders is fueling the demand for apheresis procedures among patients. According to World Health Organization, annually around 18 million people suffer from cancer globally. Such surging instances of life-threatening health conditions requiring apheresis or therapeutic plasmapheresis procedures contribute to market growth.
Market restraints
High costs associated with apheresis devices, procedures, and lack of awareness about therapeutic plasmapheresis especially in developing regions limit widespread adoption of technology. Additionally, stringent regulatory approvals and safety concerns pertaining to plasmapheresis also acts as a restraint.
Segment Analysis
The Apheresis Equipment market can be segregated into plasmapheresis, plateletpheresis, and leukapheresis based on type of component collection. Among them, the plasmapheresis segment dominates the market owing to high demand for plasma collection for fractionation purposes to manufacture plasmatic drugs and proteins. Plasma collection accounts for over 40% of revenue in this market due to rising usage of immunoglobulins and albumin in healthcare facilities.
Global Analysis
North America holds the largest share in the apheresis equipment market and is expected to remain dominant during the forecast period. This is attributed to well-established healthcare infrastructure, high plasma collection activities, and presence of major market players in the region. The U.S. generates highest revenue as it has dominant fractionators and large plasma collection centers. Europe holds the second largest share due to widespread adoption of apheresis procedures for hematology and immunology applications. Asia Pacific is expected witness fastest growth during the forecast period owing to growing healthcare industry, increasing medical tourism, rising disposable incomes, and expanding patient pool of chronic disorders in developing countries such as India and China.
Get this Report in Japanese Language - アフェレシス機器市場
Get this Report in Korean Language - 아페리시스 장비 시장
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)